Arsenite induces DNA-protein crosslinks and cytokeratin expression in the WRL-68 human hepatic cell line

Carcinogenesis

Volumn 21, Issue 4, 2000, Pages 701-706

  Ramirez P ^a   Del Razo, L M ^b   Gutierrez Ruiz M C ^c   Gonsebatt, M E ^a  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c UNIVERSIDAD AUTÓNOMA METROPOLITANA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; CYTOKERATIN; CYTOKERATIN 18; THIOL GROUP;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CROSS LINKING; DNA DAMAGE; DOSE RESPONSE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INTERMEDIATE FILAMENT; LIVER CELL CULTURE; METHYLATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

EID: 0342748616     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.4.701     Document Type: Article

References (31)

1. Nietert, N.C., Kellicutt, L.M. and Kubinski, H. (1974) DNA-protein complexes produced by a carcinogen, β-propiolactone. Cancer Res., 34, 859-864.
2. Miller, C.A., Cohen, M.D. and Costa, M. (1991) Complexing of actin and other nuclear proteins to DNA by cis-diaminochloroplatinum(II) and chromium compounds. Carcinogenesis, 12, 269-276.
3. Zhitkovich, A. and Costa, M. (1992) A simple, sensitive assay to detect DNA-protein crosslinks in intact cells and in vivo. Carcinogenesis, 13, 1485-1489.
4. Toyokuni, S., Mori, T., Hiai, H. and Dizdaroglu, M. (1995) Treatment of wistar rats with renal carcinogen, ferric nitrilotriacetate, causes DNA-protein cross-linking between thymine and tyrosine in their renal chromatin. Int. J. Cancer, 62, 309-313.
5. Casanova, M., Morgan, K.T., Steinhagen, W.H., Everitt, J.I., Popp, J.A. and Heck, H.d'A. (1994) DNA-protein cross-links and cell replication at specific sites in the nose of F344 rats exposed subchronically to formaldehyde. Fundam. Appl. Toxicol., 23, 525-536.
6. Conaway, C.C., Whysner, J., Verna, L.K. and Williams, G.M. (1996) Formaldehyde mechanistic data and risk assessment: endogenous protection from DNA adduct formation. Pharmacol. Ther., 71, 29-55.
7. IARC (1980) Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol. 23. Some Metal and Metallic Compounds. IARC, Lyon.
8. Chen, C.-J., Chen, C.W., Wu, M.-M. and Kuo, T.-L. (1992) Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br. J. Cancer, 66, 888-892.
9. Gonsebatt, M.E., Vega, L., Salazar, A.M., Montero, R., Guzman, P., Blas, J., Del Razo, L.M., García-Vargas, G., Albores, A., Cebrián, M.E., Kelsh, M. and Ostrosky-Wegman, P. (1997) Cytogenetic effects in human exposure to arsenic. Mutat. Res., 386, 219-228.
10. Crecelius, E.A., Bloom, N.S., Cowan, C.E. and Jenne, E.A. (1986) Determination of arsenic species in limnological samples by hydride generation atomic absorption spectrosropy. In Speciation of Selenium and Arsenic in Natural Waters and Sediments. Arsenic Speciation, Electric Power Research Institute, Palo Alto, CA, Vol. 2, pp. 1-28.
11. Styblo, M. and Thomas, D.J. (1995) In vitro inhibition of glutathione reductase by arsenotriglutathione. Biochem. Pharmacol., 49, 971-977.
12. Clewell, H.J., Gentry, P.R., Barton, H.A., Shipp, A.M., Yager, J.W. and Andersen, M.E. (1999) Requirements for a biologically realistic cancer risk assessment for inorganic arsenic. Int. J. Toxicol., 18, 131-147.
13. Gutierrez-Ruíz, M.C., Bucio, L., Souza, V., Gomez, J.L., Campos, C. and Cárabez, A. (1994) Expression of some hepatocyte-line functional properties of WRL-68 in culture. In Vitro Cell Dev. Biol., 30A, 366-371.
14. Squibb, K.S. and Fowler, B.A. (1983) The toxicity of arsenic and its compounds. In B.A. Fowler (ed.) Biological and Environmental Effects of Arsenic. Elsevier, Amsterdam, The Netherlands, pp. 223-269.
15. Ward, W.S., Schmidt, W.N., Schmidt, C.A. and Hnilica, L.S. (1984) Association of cytokeratin p39 with DNA in intact Novikoff hepatoma cells. Proc. Natl Acad. Sci. USA, 81, 419-423.
16. Aligué, R., Bastos, R., Serratosa, J., Enrich, C., James, P., Pujades, C. and Bachs, O. (1990) Increase in a 55-kDa keratin-like protein in the nuclear matrix of rat liver cells during proliferative activation. Exp. Cell Res., 186, 346-353.
17. Wedrychowski, A., Schmidt, W.N., Steve Ward, W. and Hnilica, L.S. (1986) Cross-linking of cytokeratins to DNA in vivo by chromium salt and cis-diamminedichloroplatinum(II). Biochemistry, 24, 1-9.
18. Hissin, P.J. and Hilf, R. (1976) A fluorometric method for detemination of oxidized and reduced glutathione in tissues. Anal. Biochem., 74, 214-226.
19. Laemmli, U.K. (1970) Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature, 277, 680-685.
20. Marafante, E. and Vahter, M., (1984) The effect of methyltransferase inhibition on the metabolism of [74As]arsenite in mice and rabbits. Chem. Biol. Interact., 50, 49-57.
21. Hughes, M.F. and Kenyon, E.M., (1998) Dose-dependent effects on the disposition of monomethylarsonic acid and dimethylarsinic acid in the mouse after intravenous administration. J. Toxicol. Environ. Health, 53, 95-112.
22. Hughes, M.F., Menache, M. and Thompson, D.J. (1994) Dose-dependent disposition of sodium arsenate in mice following acute oral exposure. Fundam. Appl. Toxicol., 22, 80-89.
23. Del Razo, L.M., Garcia-Vargas, G.G., Vargas, H., Albores, A., Gonsebatt, M.E., Montero, R., Ostrosky-Wegman, P., Kelsh, M. and Cebrian, M.E. (1997) Altered profile of urinary arsenic metabolites in adults with chronic arsenicism. A pilot study. Arch. Toxicol., 71, 211-217.
24. Styblo, M., Vega, L., Germolec, D.R., Del Razo, L.M., Luster, M.I., Wang, C., Cullen, W.R. and Thomas, D.J. (1999) Metabolism and toxicity of arsenicals in cultured cells. In Chappell, W.R., Abernathy, C.O. and Calderon, R.L. (eds) Arsenic Exposure and Health Effects. Elsevier, Amsterdam, The Netherlands, pp. 311-323.
25. Styblo, M., Del Razo, L.M., LeCluyse, E.L., Hamilton, G.A., Wang, C., Cullen, W.R. and Thomas, D.J. (1999) Metabolism of arsenic in primary cultures of human and rat hepatocytes. Chem. Res. Toxicol., 12, 560-565.
26. Germolec, D.R., Yoshida, T., Gaido, K.J., Wilmer, J.L., Simeonova, P.P., Kayama, F., Burleson, F., Dong, W., Lange, R.W. and Luster, M.I. (1996) Arsenic induces overexpression of growth factors in human keratinocytes. Toxicol. Appl. Pharmacol., 141, 308-318.
27. Kachinskas, D.J., Qin, Q., Phillips, M.A. and Rice, R.H. (1997) Arsenate suppression of human keratinocytes programming. Mutat. Res., 386. 253-261.
28. Fuchs, E. (1996) The cytoskeleton and disease: genetic disorders of intermediate filaments. Annu. Rev. Genet., 30, 197-231.
29. Wedrychowski, A., Schmidt, W.N. and Hnilica, L.S. (1986) DNA-protein crosslinking by heavy metals in Novikoff Hepatoma. Arch. Biochem. Biophys., 252, 397-402.
30. Ramírez, P., Eastmond, D.A., Laclette, J.P. and Ostrosky-Wegman, P. (1997) Disruption of microtubule assembly and spindle formation as a mechanism for the induction of aneuploid cells by sodium arsenite and vanadium pentoxide. Mutat. Res., 386, 291-298.
31. Vega, L., Gonsebatt, M.E. and Ostrosky-Wegman, P. (1995) Aneugenic affect of sodium arsenite on human lymphocytes in vitro: an individual susceptibility affect detected. Mutat. Res., 334, 365-373.